26 May 2013
Keywords: wuxi, enters, three-year, adme, analysis, accord, pfizer
Article | 17 November 2008
WuXi PharmaTech, a drug R&D outsourcing company with operations in China and the USA, has signed a new three-year, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2008
24 May 2013
© 2013 thepharmaletter.com